Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Clinical Efficacy of Probiotics in Prevention of Infectious Diseases Among Hospitalized Patients in Icu and Non-Icu Wards in Clinical Randomized Trials: A Systematic Review Publisher



Darbandi A1 ; Banar M2 ; Koupaei M3 ; Afifirad R4 ; Asadollahi P5 ; Bafandeh E6 ; Rasooli I7 ; Emamie A2 ; Navidifar T8 ; Owlia P1, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Molecular Microbiology Research Center, Shahed University, Tehran, Iran
  2. 2. Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Microbiology and Immunology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  4. 4. Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
  6. 6. Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
  7. 7. Molecular Microbiology Research Center, Faculty of Sciences, Shahed University, Tehran, Iran
  8. 8. Shoushtar Faculty of Medical Sciences, Shoushtar, Iran

Source: Health Science Reports Published:2023


Abstract

Background and Aims: The present study aimed to review probiotics' clinical efficacy in preventing infectious diseases among hospitalized patients in ICU and non-ICU wards. Methods: A search of Medline, EMBASE, The Cochrane Library, Science Direct, Open Grey, and Google Scholar was conducted for eligible publications from 2002 to 2020 following the requirements outlined in the PRISMA guideline. The search strategy was based on the combination of the following terms: “probiotics,” “prebiotics,” “synbiotics,” and “cross-infection.” The logical operators “AND” (or the equivalent operator for the databases) and “OR” (e.g., probiotics OR prebiotics OR synbiotics) were used. Results: The results indicated that the probiotic consumption caused a significant reduction in antibiotic-associated diarrhea (AAD) and Clostridioides difficile infection (CDI) in 2/8 randomized clinical trials (RCTs) investigating AAD/CDI. Also, 5/12 clinical trials highlighted the considerable effects of probiotics on the reduction or prevention of ventilator associated pneumoniae (VAP), so the mean prevalence of VAP was lower in the probiotic group than in the placebo group. The total rate of nosocomial infections among preterm infants was nonsignificantly higher in the probiotic group compared to the control group. Conclusion: This systematic review shows that the administration of probiotics has moderate preventive or mitigating effects on the occurrence of VAP in ICU patients, CDI, AAD, and nosocomial infections among children. Consequently, applying antibiotics along with the proper probiotic species can be advantageous. © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.